FindMyKOL

Ekaterina Bakradze, MD

Basic profile

Neurology

ORCID↗NPI↗
✓ Itemized record
RegionBirmingham, AL · SoutheastSpecialtyNeurologyFocusNeurology
Active KOLFindMyKOL type: NationalLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Ekaterina Bakradze is a Neurology physician. OpenAlex indexes 82 publications with 683 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

683citations

Citations across these publications.

13h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.4%
    Statin40.6%
    Atorvastatin Calcium55%Rosuvastatin Calcium45%
    Part D≥21 patients
    PCSK9 Inhibitor18.4%
    Repatha Sureclick60%Repatha Syringe40%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    12.6%
    Factor Xa inhibitor12.6%
    Eliquis100%
    Part D<11 patients
  • Nervous system

    5%
    Other antiepileptics5%
    Levetiracetam100%
    Part D<11 patients
Where care is delivered (Part B)90.6% facility · 9.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”